An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: Applications in mice with bone property altering Lrp5 mutations

Journal of Bone and Mineral Research

Volumn 28, Issue 10, 2013, Pages 2081-2093

  Ayturk, Ugur M ^a,b   Jacobsen, Christina M ^a   Christodoulou, Danos C ^b   Gorham, Joshua ^b   Seidman, Jonathan G ^b   Seidman, Christine E ^b,d   Robling, Alexander G ^c   Warman, Matthew L ^a,b,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

cells of bone; diseases and disorders of related to bone; genetic animal models; molecular pathway development; statistical methods; WNT catenin LRPS

Indexed keywords

COLLAGENASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MESSENGER RNA;

ALLELE; ARTICLE; BLOOD; BONE MARROW; BONE MASS; DIAPHYSIS; GENE EXPRESSION; GENE IDENTIFICATION; GENOTYPE; MISSENSE MUTATION; MOUSE; NONHUMAN; RNA SEQUENCE; SKELETAL MUSCLE;

CELLS OF BONE; DISEASES AND DISORDERS OF/RELATED TO BONE; GENETIC ANIMAL MODELS; MOLECULAR PATHWAY DEVELOPMENT; STATISTICAL METHODS; WNT/Β-CATENIN/LRPS;

ANIMALS; BONE MARROW; COMPUTER SIMULATION; DIAPHYSES; GENE EXPRESSION REGULATION; GENE LIBRARY; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MALE; MICE; MUSCLE, SKELETAL; MUTATION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TIBIA;

EID: 84884514583     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1946     Document Type: Article

References (77)

1. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP., High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002; 346 (20): 1513-21.
2. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML., Osteoporosis-Pseudoglioma Syndrome Collaborative Group. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; 107 (4): 513-23.
3. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML., A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002; 70 (1): 11-9.
4. Clement-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G., Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation bone mass in mice. Proc Natl Acad Sci U.S.A. 2005; 102 (48): 17406-11.
5. Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG., Lrp5 functions in bone to regulate bone mass. Nat Med. 2011; 17 (6): 684-91.
6. Niziolek PJ, Warman ML, Robling AG., Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner. Bone. 2012; 51 (3): 459-65.
7. Sawakami K, Robling AG, Ai M, Pitner ND, Liu D, Warden SJ, Li J, Maye P, Rowe DW, Duncan RL, Warman ML, Turner CH., The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem. 2006; 281 (33): 23698-711.
8. Saxon LK, Jackson BF, Sugiyama T, Lanyon LE, Price JS., Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it. Bone. 2011; 49 (2): 184-93.
9. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA., Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol. 2001; 3 (7): 683-6.
10. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D., Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem. 2005; 280 (20): 19883-7.
11. Semenov M, Tamai K, He X., SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 2005; 280 (29): 26770-5.
12. Semënov MV, Tamai K, Brott BK, Kühl M, Sokol S., He X Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol. 2001; 11 (12): 951-61.
13. Ai M, Holmen SL, Van Hul W, Williams BO, Warman ML., Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol. 2005; 25 (12): 4946-55.
14. Bourhis E, Wang W, Tam C, Hwang J, Zhang Y, Spittler D, Huang OW, Gong Y, Estevez A, Zilberleyb I, Rouge L, Chiu C, Wu Y, Costa M, Hannoush RN, Franke Y, Cochran AG., Wnt antagonists bind through a short peptide to the first beta-propeller domain of LRP5/6. Structure. 2011; 19 (10): 1433-42.
15. Semenov MV, He X., LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem. 2006; 281 (50): 38276-84.
16. Malone JH, Oliver B., Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol. 2011; 9: 34.
17. Ozsolak F, Milos PM., RNA sequencing: advances, challenges and opportunities. Nate Rev Genet. 2011; 12 (2): 87-98.
18. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B., Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008; 5 (7): 621-8.
19. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder M., The transcriptional landscape of the yeast genome defined by RNA sequencing. Science. 2008; 320 (5881): 1344-9.
20. Davanian H, Stranneheim H, Båge T, Lagervall M, Jansson L, Lundeberg J, Yucel-Lindberg T., Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencing. PloS One. 2012; 7 (9): e46440.
21. Jäger M, Ott CE, Grünhagen J, Hecht J, Schell H, Mundlos S, Duda GN, Robinson PN, Lienau J., Composite transcriptome assembly of RNA-seq data in a sheep model for delayed bone healing. BMC Genomics. 2011; 12: 158.
22. Yao B, Zhao Y, Zhang H, Zhang M, Liu M, Liu H, Li J., Sequencing and de novo analysis of the Chinese Sika deer antler-tip transcriptome during the ossification stage using Illumina RNA-Seq technology. Biotechnol Lett. 2012; 34 (5): 813-22.
23. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T., The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006; 7: 3.
24. Grant GR, Farkas MH, Pizarro AD, Lahens NF, Schug J, Brunk BP, Stoeckert CJ, Hogenesch JB, Pierce EA., Comparative analysis of RNA-Seq alignment algorithms and the RNA-Seq unified mapper (RUM). Bioinformatics. 2011; 27 (18): 2518-28.
25. Robinson MD, McCarthy DJ, Smyth GK., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26 (1): 139-40.
26. Wasserman E, Webster D, Kuhn G, Attar-Namdar M, Muller R, Bab I., Differential load-regulated global gene expression in mouse trabecular osteocytes. Bone. 2013; 53 (1): 14-23.
27. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA., Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17 (10): 1235-41.
28. Benjamini Y, Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995; 57 (1): 289-300.
29. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G., Durbin R; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25 (16): 2078-9.
30. Carlson M, Pages H, Aboyoun P, Falcon S, Morgan M, Sarkar D, Lawrence M., 2009; Genomic features: tools for making and manipulating transcript centric annotations [Internet]. Bioconductor: Open Source Software for Bioinformatics; 2009 [cited 2013 Apr 6]. Available from: http://www.bioconductor.org/packages/2. 6/bioc/html/GenomicFeatures.html.
31. McMahon AP, Champion JE, McMahon JA, Sukhatme VP., Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. Development. 1990; 108 (2): 281-7.
32. Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP, Pacifici R., Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest. 1998; 102 (10): 1850-9.
33. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T., IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990; 145 (10): 3297-303.
34. Ha J, Choi HS, Lee Y, Kwon HJ, Song YW, Kim HH., CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis. J Immunol. 2010; 184 (9): 4717-24.
35. Asagiri M, Takayanagi H., The molecular understanding of osteoclast differentiation. Bone. 2007; 40 (2): 251-64.
36. Wagner EF., Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis. 2010; 69(Suppl 1): i86-8.
37. Choi HY, Dieckmann M, Herz J, Niemeier A., Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PloS One. 2009; 4 (11): e7930.
38. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO., Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res. 2004; 19 (12): 2033-40.
39. Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C, Jaffe DB, Nusbaum C, Gnirke A., Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011; 12 (2): R18.
40. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ, Keira Cheetham R, Cox AJ, Ellis DJ, Flatbush MR, Gormley NA, Humphray SJ, Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ, Obradovic B, Ost T, Parkinson ML, Pratt MR, Rasolonjatovo IM, Reed MT, Rigatti R, Rodighiero C, Ross MT, Sabot A, Sankar SV, Scally A, Schroth GP, Smith ME, Smith VP, Spiridou A, Torrance PE, Tzonev SS, Vermaas EH, Walter K, Wu X, Zhang L, Alam MD, Anastasi C, Aniebo IC, Bailey DM, Bancarz IR, Banerjee S, Barbour SG, Baybayan PA, Benoit VA, Benson KF, Bevis C, Black PJ, Boodhun A, Brennan JS, Bridgham JA, Brown RC, Brown AA, Buermann DH, Bundu AA, Burrows JC, Carter NP, Castillo N, Catenazzi MCE, Chang S, Cooley RN, Crake NR, Dada OO, Diakoumakos KD, Dominguez-Fernandez B, Earnshaw DJ, Egbujor UC, Elmore DW, Etchin SS, Ewan MR, Fedurco M, Fraser LJ, Fuentes Fajardo KV, Scott Furey W, George D, Gietzen KJ, Goddard CP, Golda GS, Granieri PA, Green DE, Gustafson DL, Hansen NF, Harnish K, Haudenschild CD, Heyer NI, Hims MM, Ho JT, Horgan AM, Hoschler K, Hurwitz S, Ivanov DV, Johnson MQ, James T, Huw Jones TA, Kang GD, Kerelska TH, Kersey AD, Khrebtukova I, Kindwall AP, Kingsbury Z, Kokko-Gonzales PI, Kumar A, Laurent MA, Lawley CT, Lee SE, Lee X, Liao AK, Loch JA, Lok M, Luo S, Mammen RM, Martin JW, McCauley PG, McNitt P, Mehta P, Moon KW, Mullens JW, Newington T, Ning Z, LingNg B, Novo SM, O'Neill MJ, Osborne MA, Osnowski A, Ostadan O, Paraschos LL, Pickering L, Pike AC, Pike AC, Chris Pinkard D, Pliskin DP, Podhasky J, Quijano VJ, Raczy C, Rae VH, Rawlings SR, Chiva Rodriguez A, Roe PM, Rogers J, Rogert Bacigalupo MC, Romanov N, Romieu A, Roth RK, Rourke NJ, Ruediger ST, Rusman E, Sanches-Kuiper RM, Schenker MR, Seoane JM, Shaw RJ, Shiver MK, Short SW, Sizto NL, Sluis JP, Smith MA, Sohna Sohna JE, Spence EJ, Stevens K, Sutton N, Szajkowski L, Tregidgo CL, Turcatti G, Vandevondele S, Verhovsky Y, Virk SM, Wakelin S, Walcott GC, Wang J, Worsley GJ, Yan J, Yau L, Zuerlein M, Rogers J, Mullikin JC, Hurles ME, McCooke NJ, West JS, Oaks FL, Lundberg PL, Klenerman D, Durbin R, Smith AJ., Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008; 456 (7218): 53-9.
41. Dohm JC, Lottaz C, Borodina T, Himmelbauer H., Substantial biases in ultra-short read data sets from high-throughput DNA sequencing. Nucleic Acids Res. 2008; 36 (16): e105.
42. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K., Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008; 26 (3): 317-25.
43. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, Turner DJ., Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G + C)-biased genomes. Nat Methods. 2009; 6 (4): 291-5.
44. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babij P, Brown EL, Hill AA, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex FJ., Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem. 2006; 281 (42): 31720-8.
45. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Bénichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W., Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet. 2003; 72 (3): 763-71.
46. Fong L, Tan K, Tran C, Cool J, Scherer MA, Elovaris R, Coyle P, Foster BK, Rofe AM, Xian CJ., Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth. Bone. 2009; 44 (6): 1151-62.
47. Nagata M, Lonnerdal B., Role of zinc in cellular zinc trafficking and mineralization in a murine osteoblast-like cell line. J Nutr Biochem. 2011; 22 (2): 172-8.
48. Purcell P, Joo BW, Hu JK, Tran PV, Calicchio ML, O'Connell DJ, Maas RL, Tabin CJ., Temporomandibular joint formation requires two distinct hedgehog-dependent steps. Proc Natl Acad Sci U S A. 2009; 106 (43): 18297-302.
49. Moeller C, Swindell EC, Kispert A, Eichele G., Carboxypeptidase Z (CPZ) modulates Wnt signaling and regulates the development of skeletal elements in the chicken. Development. 2003; 130 (21): 5103-11.
50. Wang L, Shao YY, Ballock RT., Carboxypeptidase Z (CPZ) links thyroid hormone and Wnt signaling pathways in growth plate chondrocytes. J Bone Miner Res. 2009; 24 (2): 265-73.
51. Liu S, Tang W, Fang J, Ren J, Li H, Xiao Z, Quarles LD., Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol. 2009; 23 (9): 1505-18.
52. Cruzan G, Bus J, Banton M, Gingell R, Carlson G., Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Regul Toxicol Pharmacol. 2009; 55 (2): 205-18.
53. Karsenty G, Park RW., Regulation of type I collagen genes expression. Int Rev Immunol. 1995; 12 (2-4): 177-85.
54. Letra A, Menezes R, Fonseca RF, Govil M, McHenry T, Murphy MJ, Hennebold JD, Granjeiro JM, Castilla EE, Orioli IM, Martin R, Marazita ML, Bjork BC, Vieira AR., Novel cleft susceptibility genes in chromosome 6q. J Dent Res. 2010; 89 (9): 927-32.
55. Eames BF, Amores A, Yan YL, Postlethwait JH., Evolution of the osteoblast: skeletogenesis in gar and zebrafish. BMC Evol Biol. 2012; 12: 27.
56. Goto T, Matsui Y, Fernandes RJ, Hanson DA, Kubo T, Yukata K, Michigami T, Komori T, Fujita T, Yang L, Eyre DR, Yasui N., Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J Bone Miner Res. 2006; 21 (5): 661-73.
57. Li SW, Arita M, Kopen GC, Phinney DG, Prockop DJ., A 1,064 bp fragment from the promoter region of the Col11a2 gene drives lacZ expression not only in cartilage but also in osteoblasts adjacent to regions undergoing both endochondral and intramembranous ossification in mouse embryos. Matrix Biol. 1998; 17 (3): 213-21.
58. Kawai T, Nomura F, Hoshino K, Copeland NG, Gilbert DJ, Jenkins NA, Akira S., Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. Oncogene. 1999; 18 (23): 3471-80.
59. Rodriguez deCordoba, Esparza-Gordillo S, Goicoechea J, de Jorge E, Lopez-Trascasa M, Sanchez-Corral P., The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol. 2004; 41 (4): 355-67.
60. Okazaki R, Toriumi M, Fukumoto S, Miyamoto M, Fujita T, Tanaka K, Takeuchi Y., Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Endocrinology. 1999; 140 (11): 5060-5.
61. Raymond MH, Schutte BC, Torner JC, Burns TL, Willing MC., Osteocalcin: genetic and physical mapping of the human gene BGLAP and its potential role in postmenopausal osteoporosis. Genomics. 1999; 60 (2): 210-7.
62. Sosnoski DM, Gay CV., Evaluation of bone-derived and marrow-derived vascular endothelial cells by microarray analysis. J Cell Biochem. 2007; 102 (2): 463-72.
63. Marine JC, Jochemsen AG., Mdmx as an essential regulator of p53 activity. Biochem Biophys Res Commun. 2005; 331 (3): 750-60.
64. Xu N, Wang Y, Li D, Chen G, Sun R, Zhu R, Sun S, Liu H, Yang G, Dong T., MDM4 overexpression contributes to synoviocyte proliferation in patients with rheumatoid arthritis. Biochem Biophys Res Commun. 2010; 401 (3): 417-21.
65. Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R., Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PloS One. 2011; 6 (12): e28503.
66. Baud'huin M, Renault R, Charrier C, Riet A, Moreau A, Brion R, Gouin F, Duplomb L, Heymann D., Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol. 2010; 221 (1): 77-86.
67. Chemel M, Le Goff B, Brion R, Cozic C, Berreur M, Amiaud J, Bougras G, Touchais S, Blanchard F, Heymann MF, Berthelot JM, Verrecchia F, Heymann D., Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis. 2012; 71 (1): 150-4.
68. Kim J, Jung Y, Sun H, Joseph J, Mishra A, Shiozawa Y, Wang J, Krebsbach PH, Taichman RS., Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem. 2012; 113 (1): 220-8.
69. Crockett JC, Schütze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ., The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Endocrinology. 2007; 148 (12): 5761-8.
70. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC., CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol. 2006; 26 (8): 2955-64.
71. Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA., Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB.J. 2010; 24 (12): 4648-59.
72. Igwe JC, Jiang X, Paic F, Ma L, Adams DJ, Baldock PA, Pilbeam CC, Kalajzic I., Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem. 2009; 108 (3): 621-30.
73. Matic I, Matthews BG, Kizivat T, Igwe JC, Marijanovic I, Ruohonen ST, Savontaus E, Adams DJ, Kalajzic I., Bone-specific overexpression of NPY modulates osteogenesis. J Musculoskelet Neuronal Interact. 2012; 12 (4): 209-18.
74. Yamada Y, Ando F, Shimokata H., Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals. Int J Mol Med. 2006; 18 (1): 119-27.
75. Okabe Y, Sano T, Nagata S., Regulation of the innate immune response by threonine-phosphatase of Eyes absent. Nature. 2009; 460 (7254): 520-4.
76. Quintana FJ, Solomon A, Cohen IR, Nussbaum G., Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PloS One. 2008; 3 (10): e3509.
77. Ress A, Moelling K., Bcr is a negative regulator of the Wnt signalling pathway. EMBO Rep. 2005; 6 (11): 1095-100. Skin Diseases